-
HEALTHCARE RESOURCE UTILIZATION IN LONG-TERM CARE RESIDENTS WITH AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE TREATED WITH BREXPIPRAZOLE
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BENEFITS OF EARLY ROMOSOZUMAB INITIATION IN PATIENTS WITH RECENT OSTEOPOROTIC HIP FRACTURES IN JAPAN
Mar 18, 2026, 21:38 PM -
LEVERAGING A NATIONAL AMBULATORY CARE CLINIC NETWORK FOR REAL-WORLD EVIDENCE: INSIGHTS FROM A LARGE US EHR DATASET
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND POTENTIAL VALUE OF T-REGULATORY CELL THERAPY IN THE TREATMENT OF MODERATE-SEVERE CROHN’S DISEASE
Mar 18, 2026, 21:38 PM -
MODELING APPROACHES FOR VACCINE INDIRECT EFFECTS IN ECONOMIC EVALUATIONS: A SCOPING REVIEW OF PUBLISHED REVIEWS AND METHODOLOGICAL GUIDANCE
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING LOBECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF MICROWAVE ABLATION VS. RADIOFREQUENCY ABLATION AND SURGICAL RESECTION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA IN THE MEXICAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
MODELLING THE FINANCIAL IMPACT OF SUPERSATURATED OXYGEN THERAPY AFTER PRIMARY PCI: A HOSPITAL PERSPECTIVE
Mar 18, 2026, 21:38 PM -
BEYOND SURVIVAL: HOW NON-HODGKIN LYMPHOMA IMPACTS WELL-BEING AND FINANCES COMPARED TO OTHER CANCERS
Mar 18, 2026, 21:38 PM -
REDESIGNING MUSCULOSKELETAL REFERRAL PATHWAYS IN EUROPE: SYSTEM-LEVEL EFFECTS OF A DIGITAL-SEROLOGY TRIAGE MODEL
Mar 18, 2026, 21:38 PM -
PREDICTORS AND OUTCOMES OF SURGERY IN PATIENTS WITH STAGE IV BREAST CANCER: INVASIVE DUCTAL CARCINOMA VERSUS INVASIVE LOBULAR CARCINOMA
Mar 18, 2026, 21:38 PM -
GASTROINTESTINAL TOLERANCE, MALNUTRITION, AND HEALTHCARE RESOURCE UTILIZATION ARE IMPACTED IN PEDIATRIC AND ADULT OUTPATIENTS USING A PEA PEPTIDE ENTERAL FORMULA
Mar 18, 2026, 21:38 PM -
MANAGEMENT BASED ON THE INSTITUTIONALIZATION OF HEALTH TECHNOLOGY ASSESSMENT (HTA): THE CASE OF THE ETONOGESTREL SUBDERMAL IMPLANT IN A BRAZILIAN PRIVATE HEALTH INSURANCE
Mar 18, 2026, 21:38 PM -
CONTEXT-AWARE GENERATIVE AI FOR EVIDENCE GENERATION, ANALOG-DRIVEN ENROLLMENT FORECASTING, AND OPERATIONAL RISK MANAGEMENT IN ONCOLOGY TRIALS
Mar 18, 2026, 21:38 PM -
COMPARING HTA DECISIONS, PRICING NEGOTIATIONS, AND REIMBURSEMENT OF INFLIXIMAB BIOLOGIC ORIGINATOR AND BIOSIMILARS IN CANADA
Mar 18, 2026, 21:38 PM -
COST-UTILITY OF LIRAGLUTIDE VERSUS ORLISTAT FOR ADULT OBESITY MANAGEMENT IN SAUDI ARABIA A PAYER PERSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
DECOMPOSITION OF GEOGRAPHIC VARIATION IN HEALTHCARE SPENDING
Mar 18, 2026, 21:38 PM -
FROM GPT-4 TO GPT-5.2: A COMPARATIVE EVALUATION OF LARGE LANGUAGE MODELS FOR EXTRACTING CLINICAL REAL-WORLD EVIDENCE DATA(RWE)
Mar 18, 2026, 21:38 PM -
COMPARING SELF-CONTROLLED CASE SERIES AND COHORT DESIGNS FOR ESTIMATING PANCREATITIS RISK ASSOCIATED WITH GLP-1 RECEPTOR AGONISTS: A MONTE CARLO SIMULATION STUDY
Mar 18, 2026, 21:38 PM -
IMPROVING AN ADHERENT PATIENT ANALYSIS OF THE DIABETES PREVENTION PROGRAM AND OUTCOMES STUDY
Mar 18, 2026, 21:38 PM
